PLAUR and urinary bladder cancer: To overcome the drawback of low delivery efficiency of conventional elemene emulsions, we developed a novel ATF24 peptide-targeted liposome carrying β-E (ATF24-PEG-Lipo-β-E) for targeted delivery into uPAR-expressing tumors and stromal cells, combined with DDP for bladder cancer treatment.